share_log
Moomoo 24/7 ·  03/20 06:33

Immunic Has Received A Notice Of Allowance From United States Patent And Trademark Office For Patent Covering Composition-Of-Matter Of Vidofludimus Calcium (IMU-838) And Related Production Method, Expected To Provide Protection Into 2039

Immunic已收到美國專利商標局批准的專利通知,該專利涵蓋了Vidofludimus Calcium的物質成分和相關生產方法,預計將在2039年之前提供保護 IMU-838

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論